Mitchell E. Horwitz, MD, discussed how omidubicel and other advances in allogeneic transplantation have impacted different hematologic oncology populations.
Mitchell E. Horwitz, MD
Advertisement
Articles by Mitchell E. Horwitz, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Data Readouts to Watch at the 2026 ASCO Annual Meeting
2
Outlining Exercise as a “Biologically Interventional Therapy” for Cancer
3
Alpha DaRT Elicits 100% Local Disease Control in Pancreatic Cancer
4
FDA Approves Dato-DXd for Metastatic Triple-Negative Breast Cancer
5